Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

Taiho Oncology, Inc. · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
egfrlung-cancernsclc
lung cancer, adjuvant, post-surgical, egfr, exon 20, early stage lung cancer, uncommon egfr mutations, nsclc, early stage, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 813052
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.